ICOS and breast cancer: While the expansion and the suppressive function of these Foxp3+ICOS+Treg cells was strictly dependent on ICOS-ligand (ICOS-L) stimulation provided by tumor plasmacytoid dendritic cells (pDCs) in ovarian cancer [28] and BC [29].